Date

    Activity

TUESDAY 3 MARCH

Predeparture briefing (via Teams dial-in)

Presentation by Southeast Asia BDMs on overview of regional health landscape, with particular focus on clinical trial demand across key markets.

Session highlights:

• Country-specific needs and trends in clinical trials
• Strategic opportunities for Australian providers
• Key organisations and agencies for collaboration, including regulatory bodies
• Pathways for engaging with potential investors and innovation partners

TUESDAY 10 MARCH

9.00am – 12.00pm

Austrade Program

Three panel sessions:

Navigating Australia’s clinical trials landscape: investment insights, innovation highlights, regulatory updates

Exploring the evolving landscape of clinical trials through three key lenses:

1. Investor Outlook: What drives investor interest in clinical trials, and how do they assess risk and opportunity in this space?

2. Success Stories: A spotlight on Australian and Singapore companies that have successfully navigated the clinical trial process and delivered impactful outcomes

3. Regulatory Synergies: A comparative look at the regulatory frameworks in Australia and Singapore, highlighting opportunities for strategic collaboration and streamlined trial execution across both regions. 

 12.00pm – 6.00pm

Individual program (personal discretionary time)

Pre-arranged one-on-one meetings.

5.00pm – 7.00pm

Stakeholder engagement and reception at Australian High Commission (or HOM Residence).

WEDNESDAY 11 MARCH

Day 1 - CTFA 2026

Thought leadership and Stage session

• Access to conference sessions and lunches
• Showcase individual and collective insights
• Opportunity to be panelist on a moderated panel discussion
• Moderate the panel discussion
• Opportunity for a company to take on this role (if not participating as a panelist)

THURSDAY 12 MARCH

Day 2 – CTFA 2026

Continuation of conference program as part of overall two-day CTFA agenda

Debrief – all Australian delegates